Spravato® (esketamine) nasal spray
A New Approach to Treating Depression
At FJ Psychological Services, we understand that depression can feel overwhelming, especially when traditional treatments haven't provided relief. Spravato® (esketamine) nasal spray is an FDA-approved treatment for adults with treatment-resistant depression (TRD) and major depressive disorder (MDD) with acute suicidal thoughts.This innovative therapy works differently from traditional antidepressants, offering new hope to those struggling with severe depression.
Spravato® is administered in our office under the supervision of trained professionals, ensuring a safe and supportive experience. If you or a loved one has been searching for alternative depression treatment options, we’re here to help.
What is Spravato®?
Spravato® (esketamine) is a prescription nasal spray designed to work differently from standard antidepressants. Unlike oral medications that target serotonin and other neurotransmitters, Spravato® acts on the NMDA receptor, helping restore brain function and rapidly reducing symptoms of depression.
This treatment is administered in-office under medical supervision and is used alongside an oral antidepressant to enhance its effectiveness.
Who Can Benefit from Spravato®?
Spravato® may be an option for adults who have not found relief with at least two different antidepressants or those experiencing severe depressive symptoms with suicidal thoughts.
You may be a candidate for Spravato® if
:✔ You have been diagnosed with treatment-resistant depression (TRD)
✔ You have major depressive disorder (MDD) with acute suicidal ideation or behavior
✔ You have tried at least two different antidepressants without significant improvement
Not sure if you qualify? Our team can conduct an evaluation to determine whether Spravato® is right for you.
What to Expect from Treatment
Step 1: Initial Consultation
Before starting Spravato®, you’ll meet with our team for a comprehensive evaluation to determine if this treatment is appropriate for your needs.
Step 2: In-Office Treatment Sessions
- Spravato® is self-administered as a nasal spray in our office under supervision.
- After taking the medication, you will relax in a comfortable treatment area for at least two hours of observation while our team monitors for potential side effects.
- You cannot drive home after treatment—you’ll need someone to accompany you or arrange transportation.
Step 3: Treatment Phases
- Induction Phase: Twice weekly for the first 4 weeks
- Maintenance Phase: Once weekly or biweekly, depending on individual response
Spravato®
Spravato® works differently for everyone, and we will adjust your treatment plan as needed. Some patients notice improvement within the first few sessions, while others may need more time to respond.
Why Choose Spravato®?
Fast-Acting Relief – Unlike traditional antidepressants, which can take weeks to work, Spravato® may start alleviating symptoms in days.
Different Mechanism of Action
Works in a unique way by targeting NMDA receptors, rather than serotonin.
Proven Effective – FDA-approved for treatment-resistant depression and major depressive disorder with suicidal ideation.
Administered in a Safe, Monitored Setting – Our experienced team ensures you’re comfortable and supported throughout the process.
Understanding Side Effects & Safety
Spravato® is generally well-tolerated, but some patients may experience temporary side effects during or after treatment. Our team will monitor you closely and address any concerns.
Possible Side Effects:
🔹 Dizziness or lightheadedness🔹 Feeling drowsy or detached from reality (dissociation)🔹 Nausea or vomiting🔹 Increased blood pressure
Most side effects resolve within a few hours. Due to possible sedation or dizziness, patients cannot drive after treatment and must arrange for transportation home.
Insurance & Cost Assistance
We know that treatment costs can be a concern, but Spravato® may be covered by insurance. Many insurance providers recognize Spravato® as a medically necessary treatment for TRD and MDD.